Medipharm Labs Corp recorded one insider sale during the past ninety days. Director Christopher David Taves disposed of shares valued at approximately 13,259 CAD. This single transaction represents the entirety of recent activity, occurring amidst an 11.8% decline in stock price. No executive buying or selling occurred within this period.